2004 -0.1 3.1 A-HEFT TRIAL Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure Inclusion criteria: patients self-identified as 1,050 black (of African descent) with NYHA class III-IV patients HF ≥3 months on standard therapy, including ACEI/ARBs, ẞ-blockers, spironolactone, diuretics 6.2 double-blinded, parallel-group, randomized, placebo-controlled Objective: Among self-identified black patients with HFREF, does […]